Close
Close
Treatment Database
osimertinib
Trade Name Tagrisso
Orphan Indication Epidermal growth factor receptor mutation-positive non-small cell lung cancer
USA Market Approval 13-11-2015
USA Designation Date 04-09-2014
Sponsor AstraZeneca Pharmaceuticals LP
P. O. Box 8355, 1800 Concord Pike
Wilmington, Delaware, 19803
More about Non-small cell lung cancer
Free Newsletter
Treatment News
Related Videos
by Abidemi Uruejoma
570 views
by Abidemi Uruejoma
4,175 views
by Abidemi Uruejoma
9,934 views
by Dr. Jules Richard Kemadjou
10,134 views